SuperworthTranslational Development Acquisition EPS TDAC
Diluted earnings per share by quarter and over the last twelve months, from 2024.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- $0.04
- −43% on a year earlier
Translational Development Acquisition's twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was $0.04, down 43% on the same quarter a year before.
Earnings per share over time
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier |
|---|---|---|---|
| Q2 FY26 | $0.04 | −43% | |
| Q1 FY26 | $0.06 | −14% | |
| Q3 FY25 | $0.08 | n/a | |
| Q2 FY25 | $0.07 | n/a | |
| Q1 FY25 | $0.07 | n/a | |
| Q3 FY24 | −$0.02 | n/a | |
| Q2 FY24 | $0.00 | n/a | |
| Q1 FY24 | $0.00 | n/a |
Against its peers
Companies in Financial Services nearest Translational Development Acquisition's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| TDACTranslational Development Acquisition | n/m | |
| CZWICitizens Community Bancorp | $1.31 | +6% a year |
| FCAPFirst Capital | $5.53 | +40% a year |
| CPSSConsumer Portfolio Services | $0.92 | +15% a year |
| RBKBRhinebeck Bancorp | $0.90 | |
| DHXDHI | $0.03 | |
| LARKLandmark Bancorp | $3.24 | +23% a year |
| OPBKOP Bancorp | $1.93 | +30% a year |
| CBFVCB Financial Services | $1.38 | −36% a year |
| MRBKMeridian | $1.84 | +14% a year |
| CFBKCF Bankshares | $2.91 | +5% a year |
| Peer median | $1.61 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Translational Development Acquisition
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.